Research Library

The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network.

Iams JD et al., 1996

​

The corpus luteum insufficiency: a multifactorial disease.

Hinney B et al., 1996

​

Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: a comparison with amniotic fluid white blood cell count.

Yoon BH et al., 1996

​

Field trial of billings ovulation method of natural family planning.

Bhargava H et al., 1996

​

Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.

de Winter JP et al., 1996

​

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Spitzer WO et al., 1996

​

Epithelial Ovarian Cancer: Epidemiology, Screening, and Prevention in Menopausal Medicine (1996)

Bass KM, 1996

​

Infertility in Novak's Gynecology, 12th Edition

Hornstin MD et al., 1996

​

Correlation between cytokine levels of amniotic fluid and histological chorioamnionitis in preterm delivery.

Negishi H et al., 1996

​

An unsuccessful attempt to relate ovulatory disturbances to changes in bone density.

Petit MA et al., 1996

​

Obstetrics: Normal and Problem Pregnancies

Gabbe SG et al., 1996

​

Endometriosis and Spontaneous Abortion in Infertility and Reproductive Medicine Clinics of North America

Daya S, 1996

​

Endometriosis: The Immunoendocrine Factor

Johnson KM, 1996

​

The Length of the Cervix and the Risk of Spontaneous Premature Delivery

Iams JD et al. 1996.

​

Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.

Evans SF et al., 1996

​

Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

Buyalos RP et al., 1996

​

Indications for and Technique of Myomectomy in Infertile Reproductive Medicine Clinical North America

Peacock LM et al., 1996

​

Cytokines and immuno-endocrine factors in recurrent miscarriage.

Regan L, 1996

​

A comparison of the ovulation method with the CUE ovulation predictor in determining the fertile period.

Fehring RJ, 1996

​

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW et al., 1995

​

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Jick H et al., 1995

​

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

No Authors Listed, 1995

​

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

No Authors Listed, 1995

​

Prophylactic estrogen in recurrent postpartum affective disorder.

Sichel DA et al., 1995

​

Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby.

Wilcox AJ et al., 1995

​